Table 1.

Patients’ clinical profiles

Patient	Age (years)	Sex	RF (IU/ml)	Disease	Focus score	ANA	Anti-Ro	Anti-La
2.4	16	M	N/A	SLE	N/A	+	−	−
2.24	15	F	<10	SLE	N/A	−	−	−
3.9	8	F	16.5	SLE	N/A	1/80	+	−
3	16	F	N/A	SLE	N/A	+	+	+
4.1	11	F	N/A	SLE	N/A	+	+	+
14	16	F	12	SLE	N/A	+	−	+
15	17	F	<10	SLE	N/A	+	−	−
24	15	F	<10	SLE	N/A	−	−	−
25	16	F	<10	SLE	N/A	+	−	−
26	16	F	86	SLE	N/A	+	+	+
27	15	F	<10	SLE, sSS	N/A	+	+	+
1	48	F	+	pSS	2.7	1/320	+	+
2	56	F	−	pSS	2.3	1/320	+	+

ANA antinuclear autoantibodies, pSS primary Sjögren’s syndrome, RF rheumatoid factor, SLE systemic lupus erythematosus, RF rheumatoid factor, sSS secondary Sjögren’s syndrome, N/A not applicable, IU/ml international units per milliliter